Focus Areas
New approaches
to health.
One technology for different applications – from clinical care to molecular research.
Discover the focus areasFrom technology
to application.
The platform brings together measurement methods, Delta evaluation and data processing. AI-assisted individual baselines are intended to extend this foundation in the future and make it useful for different applications.
technology platformAssay · Delta
Data · AI baseline
Cancer
monitoring
Interpreting changes over time.
02 / Health-related perspectiveHealthMarker
Considering health individually and over time.
03 / Healthcare perspectiveMCED Gatekeeper
Guidance within a staged diagnostic pathway.
04 / Research perspectiveMolecular research
Exploring new relationships relevant to the platform.
01 / Cancer monitoring
Keeping track
of change.
During treatment and follow-up care, it is important to understand how an individual's clinical course evolves. Repeated measurements are intended to add to this temporal perspective and make changes relative to a personal baseline easier to track.
The aim is to provide additional guidance for clinical interpretation and targeted further investigation.
- 01
Starting point
An individual reference point.
- 02
Comparison over time
Repeated measurements over time.
- 03
Clinical interpretation
Considering changes in context.
Priority clinical application pathway
The developed blood-test platform provides the starting point. Further development and validation for cancer monitoring are the focus.
Treatment support and follow-up care
Closer observation of biological changes is intended to complement clinical care. Imaging and further diagnostic assessment remain part of the overall medical picture.
02 / HealthMarker
Health.
A personal perspective.
Application rationale
HealthMarker applies the platform concept to a health-related, preventive perspective. The focus is on how a person's biological signals change over longer periods.
An individual baseline is intended to serve as a personal reference point. This opens up the prospect of health guidance that takes greater account of the individual's course over time.
Health-related development pathway
HealthMarker is designed as a distinct extension of the platform. This development pathway centres on the combination of repeated measurements, a personal baseline and digital analysis.
Closer to everyday life
Miniaturisation and the future development of point-of-care measurement systems are intended to bring diagnostic applications closer to everyday life. AI-assisted analysis is intended to compare measurement results with individual baselines, identify changes over time and automatically notify the treating care team when notable deviations occur.
03 / MCED Gatekeeper
Guidance.
Before the next step.
The Gatekeeper concept aims to provide easily accessible cancer screening that indicates possible cancers and is intended to help assess the extent of the cancer burden in the populations examined. On this basis, abnormal findings are to undergo targeted further investigation, and any necessary medical action is to be taken.
A particular focus is on emerging and developing countries, where diagnostic services are often available only to a limited extent. There, screening is intended to provide an accessible first step towards early cancer detection and to be integrated into structured pathways to further medical care.
Initial
guidance
Gatekeeper
Preliminary assessment
Further
diagnostic assessment
In the medical context
A distinct application concept
The Gatekeeper role is conceived as a further platform pathway. Its suitability and integration into different healthcare structures are subjects of further development and validation.
Expanding access to diagnostics
Particularly in healthcare systems with limited resources, this opens up the prospect of a more accessible first step – linked to a structured pathway to further investigation.
04 / Molecular research
Thinking ahead.
To the molecular level.
Application rationale
The molecular perspective broadens the scientific view of the platform. It focuses on biological relationships that could give rise to additional diagnostic approaches over the long term.
Research and early-stage development
This field is at an early stage of development. The focus is on scientific exploration and the assessment of potential future applications.
New insights are intended to deepen understanding of the platform and open up potential extensions. The molecular field is therefore part of CARCIMUN's long-term perspective.
Clear priorities.
Open perspectives.
The focus areas build on the same technological foundation. Their development addresses different questions – from the priority clinical pathway to long-term research.
Cancer
monitoring
Priority application pathway based on the developed blood-test platform.
Focus: further development and validationHealthMarker
Health-related development with an individual longitudinal perspective.
MCED Gatekeeper
Concept for a preliminary role in staged diagnostic pathways.
Focus: application-specific developmentMolecular
research
Early research and preliminary development for potential extensions of the platform.
Focus: scientific explorationOne platform.
New possibilities for health.